{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:14:28Z","timestamp":1788488068141,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","award":["American Lebanese Syrian Associated Charities"],"award-info":[{"award-number":["American Lebanese Syrian Associated Charities"]}],"id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04701-0","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:00:26Z","timestamp":1788487226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Undifferentiated round cell sarcoma with CIC::NUTM1 fusion: expanding the clinicopathologic spectrum of a rare molecular variant of CIC-rearranged sarcoma"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-5074","authenticated-orcid":false,"given":"Faizan","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sookdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieh-Anh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thelma B.","family":"Velasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy E.","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe M.","family":"Milano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine H.","family":"de Oliviera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Stracuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Alaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene C.","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"4701_CR1","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddl136","volume":"15","author":"M Kawamura-Saito","year":"2006","unstructured":"Kawamura-Saito M, Yamazaki Y, Kaneko K et al (2006) Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 15:2125\u20132137. https:\/\/doi.org\/10.1093\/hmg\/ddl136","journal-title":"Hum Mol Genet"},{"key":"4701_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/path.5053","volume":"245","author":"S Watson","year":"2018","unstructured":"Watson S, Perrin V, Guillemot D et al (2018) Transcriptomic definition of molecular subgroups of small round cell sarcomas. J Pathol 245:29\u201340. https:\/\/doi.org\/10.1002\/path.5053","journal-title":"J Pathol"},{"key":"4701_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100103","volume":"36","author":"K Linos","year":"2023","unstructured":"Linos K, Dermawan JK, Bale T et al (2023) Expanding the molecular diversity of CIC-rearranged sarcomas with novel and very rare partners. Mod Pathol 36:100103. https:\/\/doi.org\/10.1016\/j.modpat.2023.100103","journal-title":"Mod Pathol"},{"key":"4701_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/gcc.3","volume":"57","author":"IM Schaefer","year":"2018","unstructured":"Schaefer IM, Dal Cin P, Landry LM et al (2018) CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies. Genes Chromosomes Cancer 57:446\u2013451. https:\/\/doi.org\/10.1002\/gcc.3","journal-title":"Genes Chromosomes Cancer"},{"key":"4701_CR5","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/PAS.0000000000001098","volume":"42","author":"S Mangray","year":"2018","unstructured":"Mangray S, Kelly DR, LeGuellec S et al (2018) Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis. Am J Surg Pathol 42:1360\u20131369. https:\/\/doi.org\/10.1097\/PAS.0000000000001098","journal-title":"Am J Surg Pathol"},{"key":"4701_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/PAS.0000000000001187","volume":"43","author":"F Le Loarer","year":"2019","unstructured":"Le Loarer F, Pissaloux D, Watson S et al (2019) Clinicopathologic features of CIC-NUTM1 sarcomas, a new molecular variant of the family of CIC-fused sarcomas. Am J Surg Pathol 43:268\u2013276. https:\/\/doi.org\/10.1097\/PAS.0000000000001187","journal-title":"Am J Surg Pathol"},{"key":"4701_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.5858\/arpa.2021-0153-OA","volume":"146","author":"S Yang","year":"2022","unstructured":"Yang S, Liu L, Yan Y et al (2022) CIC-NUTM1 Sarcomas Affecting the Spine Arch. Pathol Lab Med 146:735\u2013741. https:\/\/doi.org\/10.5858\/arpa.2021-0153-OA","journal-title":"Pathol Lab Med"},{"key":"4701_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/his.14630","volume":"81","author":"LE Biederman","year":"2022","unstructured":"Biederman LE, Lee K, Yeager ND et al (2022) CIC::NUTM1 sarcoma mimicking primitive myxoid mesenchymal tumour of infancy: report of a case. Histopathology 81:131\u2013133. https:\/\/doi.org\/10.1111\/his.14630","journal-title":"Histopathology"},{"issue":"9","key":"4701_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30348","volume":"70","author":"Y Ma","year":"2023","unstructured":"Ma Y, Feng J, Ding D et al (2023) CIC-NUTM1 sarcoma in an 8-year-old female patient with a new fusion: a case report. Pediatr Blood Cancer e30348. https:\/\/doi.org\/10.1002\/pbc.30348","journal-title":"Pediatr Blood Cancer"},{"key":"4701_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-024-01499-w","volume":"19","author":"L Zhao","year":"2024","unstructured":"Zhao L, He H, Ren J et al (2024) CIC::NUTM1 sarcomas occurred in soft tissues of upper limbs: a rare case report and literature review. Diagn Pathol 19:76. https:\/\/doi.org\/10.1186\/s13000-024-01499-w","journal-title":"Diagn Pathol"},{"key":"4701_CR11","doi-asserted-by":"publisher","first-page":"e31085","DOI":"10.1002\/pbc.31085","volume":"71","author":"B Jan","year":"2024","unstructured":"Jan B, Filip K, Lenka K et al (2024) CIC::NUTM1 sarcoma in a 6-year-old male patient arising from the choroid plexus of the lateral ventricle: A case report. Pediatr Blood Cancer 71:e31085. https:\/\/doi.org\/10.1002\/pbc.31085","journal-title":"Pediatr Blood Cancer"},{"key":"4701_CR12","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.mayocp.2024.07.012","volume":"99","author":"J Torres-Mora","year":"2024","unstructured":"Torres-Mora J, Erickson LA (2024) CIC-Rearranged Round Cell Sarcoma. Mayo Clin Proc 99:1528\u20131529. https:\/\/doi.org\/10.1016\/j.mayocp.2024.07.012","journal-title":"Mayo Clin Proc"},{"key":"4701_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1519335","volume":"15","author":"W Jin","year":"2025","unstructured":"Jin W, Dong K, Yang F et al (2025) Cerebral CIC-NUTM1 rearrangement sarcoma- case report and review of the literature. Front Oncol 15:1519335. https:\/\/doi.org\/10.3389\/fonc.2025.1519335","journal-title":"Front Oncol"},{"key":"4701_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.36401\/JIPO-24-28","volume":"8","author":"C Torrado","year":"2025","unstructured":"Torrado C, Nassif Haddad E, Somaiah N et al (2025) Advancing understanding and therapeutic strategies for NUT sarcomas: comprehensive review of the literature and two cases. J Immunother Precis Oncol 8:113\u2013120. https:\/\/doi.org\/10.36401\/JIPO-24-28","journal-title":"J Immunother Precis Oncol"},{"key":"4701_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.5858\/arpa.2024-0407-OA","volume":"149","author":"SC Koo","year":"2025","unstructured":"Koo SC, Cardenas M, Stow P et al (2025) Comparison of Molecular Testing Methodologies for CIC-Rearranged Sarcomas. Arch Pathol Lab Med 149:913\u2013921. https:\/\/doi.org\/10.5858\/arpa.2024-0407-OA","journal-title":"Arch Pathol Lab Med"},{"key":"4701_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06485-7","volume":"9","author":"M Rusch","year":"2018","unstructured":"Rusch M, Nakitandwe J, Shurtleff S et al (2018) Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. Nat Commun 9:3962. https:\/\/doi.org\/10.1038\/s41467-018-06485-7","journal-title":"Nat Commun"},{"key":"4701_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00428-025-04231-1","volume":"488","author":"G Del Vecchio","year":"2026","unstructured":"Del Vecchio G, Alaggio R, Stracuzzi A et al (2026) Superficially located CIC::DUX4-rearranged sarcomas in children: insights from a long-term survival case series. Virchows Arch 488:887\u2013896. https:\/\/doi.org\/10.1007\/s00428-025-04231-1","journal-title":"Virchows Arch"},{"key":"4701_CR18","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/PAS.0000000000000846","volume":"41","author":"CR Antonescu","year":"2017","unstructured":"Antonescu CR, Owosho AA, Zhang L et al (2017) Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115. Cases Am J Surg Pathol 41:941\u2013949. https:\/\/doi.org\/10.1097\/PAS.0000000000000846","journal-title":"Cases Am J Surg Pathol"},{"key":"4701_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/PAS.0000000000002403","volume":"49","author":"S Cetin","year":"2025","unstructured":"Cetin S, Unverengil G, Yilmaz I et al (2025) The Extensive Case Series of 21 CIC::DUX4, 18 BCOR::CCNB3 and 148 Ewing\u2019s Sarcomas From a Single Center. Am J Surg Pathol 49:837\u2013853. https:\/\/doi.org\/10.1097\/PAS.0000000000002403","journal-title":"Am J Surg Pathol"},{"key":"4701_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/his.15341","volume":"86","author":"RT Macedo","year":"2025","unstructured":"Macedo RT, Baranovska-Andrigo V, Pancsa T et al (2025) Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC-rearranged sarcomas: a study of 48 molecularly confirmed cases. Histopathology 86:423\u2013432. https:\/\/doi.org\/10.1111\/his.15341","journal-title":"Histopathology"},{"key":"4701_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/modpathol.2016.140","volume":"29","author":"YP Hung","year":"2016","unstructured":"Hung YP, Fletcher CD, Hornick JL (2016) Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics. Mod Pathol 29:1324\u20131334. https:\/\/doi.org\/10.1038\/modpathol.2016.140","journal-title":"Mod Pathol"},{"key":"4701_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00428-024-03863-z","volume":"485","author":"S Nishino","year":"2024","unstructured":"Nishino S, Kojima N, Sugino H et al (2024) MUC5AC immunoreactivity in scattered tumor cells is useful for diagnosing CIC-rearranged sarcoma. Virchows Arch 485:359\u2013363. https:\/\/doi.org\/10.1007\/s00428-024-03863-z","journal-title":"Virchows Arch"},{"key":"4701_CR23","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41379-022-01078-8","volume":"35","author":"N Kojima","year":"2022","unstructured":"Kojima N, Arai Y, Satomi K et al (2022) Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall. Mod Pathol 35:1439\u20131448. https:\/\/doi.org\/10.1038\/s41379-022-01078-8","journal-title":"Mod Pathol"},{"key":"4701_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","volume":"164","author":"D Sturm","year":"2016","unstructured":"Sturm D, Orr BA, Toprak UH et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2016.01.015","journal-title":"Cell"},{"key":"4701_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/gcc.22454","volume":"56","author":"YC Kao","year":"2017","unstructured":"Kao YC, Sung YS, Chen CL et al (2017) ETV transcriptional upregulation is more reliable than RNA sequencing algorithms and FISH in diagnosing round cell sarcomas with CIC gene rearrangements. Genes Chromosomes Cancer 56:501\u2013510. https:\/\/doi.org\/10.1002\/gcc.22454","journal-title":"Genes Chromosomes Cancer"},{"key":"4701_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/his.13252","volume":"71","author":"A Yoshida","year":"2017","unstructured":"Yoshida A, Arai Y, Kobayashi E et al (2017) CIC break-apart fluorescence in-situ hybridization misses a subset of CIC-DUX4 sarcomas: a clinicopathological and molecular study. Histopathology 71:461\u2013469. https:\/\/doi.org\/10.1111\/his.13252","journal-title":"Histopathology"},{"key":"4701_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/15384101.2018.1450029","volume":"17","author":"L Sim\u00f3n-Carrasco","year":"2018","unstructured":"Sim\u00f3n-Carrasco L, Jim\u00e9nez G, Barbacid M et al (2018) The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer. Cell Cycle 17:702\u2013711. https:\/\/doi.org\/10.1080\/15384101.2018.1450029","journal-title":"Cell Cycle"},{"key":"4701_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw7781","volume":"5","author":"D Bosnakovski","year":"2019","unstructured":"Bosnakovski D, da Silva MT, Sunny ST et al (2019) A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death. Sci Adv 5:eaaw7781. https:\/\/doi.org\/10.1126\/sciadv.aaw7781","journal-title":"Sci Adv"},{"key":"4701_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00357-4","volume":"10","author":"D Bosnakovski","year":"2021","unstructured":"Bosnakovski D, Ener ET, Cooper MS et al (2021) Inactivation of the CIC-DUX4 oncogene through P300\/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma. Oncogenesis 10:68. https:\/\/doi.org\/10.1038\/s41389-021-00357-4","journal-title":"Oncogenesis"},{"key":"4701_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1158\/1541-7786.Mcr-25-0624","volume":"24","author":"C Luck","year":"2026","unstructured":"Luck C, Luo Y, Vasileva E et al (2026) Modeling of Capicua Family Fusion Oncoprotein-Driven Cancers Reveals Gene-Specific Functionality. Mol Cancer Res 24:337\u2013355. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-25-0624","journal-title":"Mol Cancer Res"},{"issue":"1","key":"4701_CR31","doi-asserted-by":"publisher","first-page":"7688","DOI":"10.1038\/s41467-025-62629-6","volume":"16","author":"W Breunis","year":"2025","unstructured":"Breunis W, Brack E, Ehlers AC et al (2025) Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target. Nat Commun 16:7688. https:\/\/doi.org\/10.1038\/s41467-025-62629-6","journal-title":"Nat Commun"},{"key":"4701_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/pin.12727","volume":"68","author":"CA French","year":"2018","unstructured":"French CA (2018) NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment. Pathol Int 68:583\u2013595. https:\/\/doi.org\/10.1111\/pin.12727","journal-title":"Pathol Int"},{"key":"4701_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.860830","volume":"12","author":"V Moreno","year":"2022","unstructured":"Moreno V, Saluja K, Pina-Oviedo S (2022) NUT carcinoma: clinicopathologic features, molecular genetics and epigenetics. Front Oncol 12:860830. https:\/\/doi.org\/10.3389\/fonc.2022.860830","journal-title":"Front Oncol"},{"key":"4701_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/his.15063","volume":"84","author":"A Yoshida","year":"2024","unstructured":"Yoshida A (2024) NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour: facts. controversies Histopathology 84:86\u2013101. https:\/\/doi.org\/10.1111\/his.15063","journal-title":"controversies Histopathology"},{"key":"4701_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/his.15204","volume":"85","author":"K Viswanathan","year":"2024","unstructured":"Viswanathan K, Hahn E, Dogan S et al (2024) The histological spectrum and immunoprofile of head and neck NUT carcinoma: a multicentre series of 30 cases. Histopathology 85:317\u2013326. https:\/\/doi.org\/10.1111\/his.15204","journal-title":"Histopathology"},{"key":"4701_CR36","doi-asserted-by":"publisher","unstructured":"French CA, Cheng ML, Hanna GJ et al (2022) Report of the First International Symposium on NUT Carcinoma Clin Cancer Res 28:2493\u20132505. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-0591","DOI":"10.1158\/1078-0432.CCR-22-0591"},{"key":"4701_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104499","volume":"10","author":"UM Lauer","year":"2025","unstructured":"Lauer UM, Awada A, Postel-Vinay S et al (2025) Final results from the phase Ia\/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma. ESMO Open 10:104499. https:\/\/doi.org\/10.1016\/j.esmoop.2025.104499","journal-title":"ESMO Open"},{"key":"4701_CR38","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/s41379-021-00792-z","volume":"34","author":"BJ Van Treeck","year":"2021","unstructured":"Van Treeck BJ, Thangaiah JJ, Torres-Mora J et al (2021) NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis. Mod Pathol 34:1547\u20131557. https:\/\/doi.org\/10.1038\/s41379-021-00792-z","journal-title":"Mod Pathol"},{"key":"4701_CR39","doi-asserted-by":"publisher","unstructured":"Papke DJ Jr., Chrisinger JSA, French CA et al (2025) MAD::NUT fusion sarcoma: a sarcoma class with NUTM1, NUTM2A, and NUTM2G fusions and possibly distinctive subtypes. Mod Pathol 38:100729. https:\/\/doi.org\/10.1016\/j.modpat.2025.100729","DOI":"10.1016\/j.modpat.2025.100729"},{"key":"4701_CR40","doi-asserted-by":"publisher","unstructured":"Wangsiricharoen S, Wakely PE Jr., Prieto VG et al (2023) Sarcoma with MGA::NUTM1 fusion: a report of three cases and literature review. Histopathology 83:712\u2013721. https:\/\/doi.org\/10.1111\/his.15004","DOI":"10.1111\/his.15004"},{"key":"4701_CR41","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/pas.0000000000002254","volume":"48","author":"P Zhu","year":"2024","unstructured":"Zhu P, Sun K, Lao IW et al (2024) Expanding the spectrum of NUTM1 -rearranged sarcoma: a clinicopathologic and molecular genetic study of 8 cases. Am J Surg Pathol 48:930\u2013941. https:\/\/doi.org\/10.1097\/pas.0000000000002254","journal-title":"Am J Surg Pathol"},{"key":"4701_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.semdp.2026.150997","volume":"43","author":"LM Warmke","year":"2026","unstructured":"Warmke LM, Folpe AL (2026) Fusion-positive soft tissue tumors: a selective review. Semin Diagn Pathol 43:150997. https:\/\/doi.org\/10.1016\/j.semdp.2026.150997","journal-title":"Semin Diagn Pathol"},{"key":"4701_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100816","volume":"38","author":"Z Alsugair","year":"2025","unstructured":"Alsugair Z, Karanian M, Meurgey A et al (2025) NUTM1\/NUTM2B-rearranged intra-abdominal sarcomas: a distinct entity from sarcomas with ESR1 overexpression as a therapeutic target. Mod Pathol 38:100816. https:\/\/doi.org\/10.1016\/j.modpat.2025.100816","journal-title":"Mod Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04701-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04701-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04701-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:00:28Z","timestamp":1788487228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04701-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":43,"alternative-id":["4701"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04701-0","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"23 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for this study was granted by the Institutional Review Boards of all institutions.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}